Lepletier, A.; Rafeek, R.A.M.; Vedis, D.; Weerakoon, H.; Ketheesan, N.; Good, M.F.; Pandey, M.
Low-Dose Interleukin-2 Therapy: A Transformative Approach for the Management of Autoimmune Complications Associated with Streptococcus pyogenes Infections. Proceedings 2025, 124, 21.
https://doi.org/10.3390/proceedings2025124021
AMA Style
Lepletier A, Rafeek RAM, Vedis D, Weerakoon H, Ketheesan N, Good MF, Pandey M.
Low-Dose Interleukin-2 Therapy: A Transformative Approach for the Management of Autoimmune Complications Associated with Streptococcus pyogenes Infections. Proceedings. 2025; 124(1):21.
https://doi.org/10.3390/proceedings2025124021
Chicago/Turabian Style
Lepletier, Ailin, Rukshan Ahamed Mohamed Rafeek, Despena Vedis, Harshi Weerakoon, Natkunam Ketheesan, Michael F. Good, and Manisha Pandey.
2025. "Low-Dose Interleukin-2 Therapy: A Transformative Approach for the Management of Autoimmune Complications Associated with Streptococcus pyogenes Infections" Proceedings 124, no. 1: 21.
https://doi.org/10.3390/proceedings2025124021
APA Style
Lepletier, A., Rafeek, R. A. M., Vedis, D., Weerakoon, H., Ketheesan, N., Good, M. F., & Pandey, M.
(2025). Low-Dose Interleukin-2 Therapy: A Transformative Approach for the Management of Autoimmune Complications Associated with Streptococcus pyogenes Infections. Proceedings, 124(1), 21.
https://doi.org/10.3390/proceedings2025124021
